Introduction of the heterozygous Atm alleles into the background of the p53+/- genotype significantly increased the incidence of mammary carcinomas to 58% (32 out of 55) and increased the average number of mammary carcinomas per mouse. This evidence concerns the gene TP53 and breast carcinoma.